Clarke, MD, a board-certified gastroenterologist and the president of the Association for Treatment of Neuroplastic Symptoms (ATNS)
Liraglutide protects against brain amyloid- 142 accumulation in female mice with early Alzheimers disease-like pathology by partially rescuing oxidative/nitrosative stress and inflammation
Patients who are already oriented toward physical activity often find that combining GLP-1 therapy with their existing habits accelerates results
However, as described earlier, its favourable effects on lipolysis and energy expenditure while reducing food intake make it an attractive option, especially if combined with the insulinotropic action of GLP-1
Tirzepatide, by contrast, activates both GLP-1 and GIP receptorsa dual action that amplifies satiety, reduces appetite-driven behavior, and may increase the body's calorie-burning capacity